ProKidney Corp Company Leadership
| PROK Stock | USD 0.94 0.05 4.85% |
About 62% of ProKidney Corp's corporate insiders are selling. The analysis of the overall insider sentiment regarding ProKidney Corp suggests that many insiders are alarmed. ProKidney Corp employs about 204 people. The company is managed by 21 executives with a total tenure of roughly 476 years, averaging almost 22.0 years of service per executive, having 9.71 employees per reported executive.
Insider Sentiment 38
Mostly Selling
Selling | Buying |
Latest Trades
| 2024-09-19 | Darin J Weber | Disposed 16412 @ 2.5 | View | ||
| 2024-07-26 | Darin J Weber | Disposed 826 @ 2.5 | View | ||
| 2024-06-13 | Pablo G Legorreta | Acquired 22617909 @ 2.42 | View | ||
| 2024-06-11 | Control Empresarial De Capital | Acquired 8264462 @ 2.42 | View | ||
| 2024-05-20 | Darin J Weber | Disposed 17238 @ 4.08 | View | ||
| 2024-04-22 | Darin J Weber | Disposed 16438 @ 2.51 | View | ||
| 2024-04-18 | Darin J Weber | Disposed 800 @ 2.54 | View | ||
| 2024-04-16 | Darin J Weber | Disposed 17238 @ 2.5 | View | ||
| 2024-04-12 | Darin J Weber | Disposed 84103 @ 1.73 | View | ||
| 2024-04-01 | Darin J Weber | Disposed 300 @ 1.69 | View | ||
| 2024-03-25 | Control Empresarial De Capital | Acquired 30000 @ 1.43 | View | ||
| 2024-03-22 | Control Empresarial De Capital | Acquired 14000 @ 1.4 | View | ||
| 2024-03-20 | Control Empresarial De Capital | Acquired 33000 @ 1.4 | View |
Monitoring ProKidney Corp's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
ProKidney |
ProKidney Corp Management Team Effectiveness
The company has return on total asset (ROA) of (0.2587) % which means that it has lost $0.2587 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.412) %, meaning that it created substantial loss on money invested by shareholders. ProKidney Corp's management efficiency ratios could be used to measure how well ProKidney Corp manages its routine affairs as well as how well it operates its assets and liabilities. Return On Equity is expected to rise to 0.06 this year, although the value of Return On Tangible Assets will most likely fall to (0.15). Total Current Liabilities is expected to rise to about 38 M this year, although the value of Liabilities And Stockholders Equity will most likely fall to about 267 M.The value of Common Stock Shares Outstanding is expected to slide to about 93.5 M. Net Loss is expected to rise to about (160.9 M) this year
ProKidney Corp Workforce Comparison
ProKidney Corp is rated below average in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 4,875. ProKidney Corp holds roughly 204 in number of employees claiming about 4% of equities under Health Care industry.
ProKidney Corp Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific ProKidney Corp insiders, such as employees or executives, is commonly permitted as long as it does not rely on ProKidney Corp's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, ProKidney Corp insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Legorreta Pablo G. few days ago Acquisition by Legorreta Pablo G. of 5289055 shares of ProKidney Corp subject to Rule 16b-3 | ||
Pereira Brian Jg over a week ago Disposition of 675234 shares by Pereira Brian Jg of ProKidney Corp subject to Rule 16b-3 | ||
Darin Weber over two weeks ago Acquisition by Darin Weber of 450000 shares of ProKidney Corp at 1.23 subject to Rule 16b-3 | ||
Coulston James over two weeks ago Acquisition by Coulston James of 650000 shares of ProKidney Corp at 1.23 subject to Rule 16b-3 | ||
Legorreta Pablo G. over two weeks ago Disposition of 748952 shares by Legorreta Pablo G. of ProKidney Corp subject to Rule 16b-3 | ||
Pereira Brian Jg over a month ago Disposition of 81928 shares by Pereira Brian Jg of ProKidney Corp subject to Rule 16b-3 | ||
Pereira Brian Jg over a month ago Acquisition by Pereira Brian Jg of 81928 shares of ProKidney Corp subject to Rule 16b-3 | ||
Fox Jennifer A. over two months ago Acquisition by Fox Jennifer A. of 42515 shares of ProKidney Corp at 10.92 subject to Rule 16b-3 |
ProKidney Corp Notable Stakeholders
A ProKidney Corp stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as ProKidney Corp often face trade-offs trying to please all of them. ProKidney Corp's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting ProKidney Corp's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Dr DVM | Founder Advisor | Profile | |
| Bruce MD | CEO Director | Profile | |
| Ulrich Ernst | EVP Technology | Profile | |
| Aparna MD | VP Development | Profile | |
| Joseph MD | VP Devel | Profile | |
| Ashley Johns | VP Operations | Profile | |
| Carla Poulson | Chief Officer | Profile | |
| Lucio Tozzi | Senior Operations | Profile | |
| James CPA | Chief Officer | Profile | |
| Richard Williams | Senior Technology | Profile | |
| Kerry MD | VP Affairs | Profile | |
| Anu Biswas | Senior Operations | Profile | |
| Mary Weger | Chief Officer | Profile | |
| Esq JD | Chief Sec | Profile | |
| Darin Weber | VP Devel | Profile | |
| Deepak Jain | Chief Officer | Profile | |
| Emily Butler | Senior Biometric | Profile | |
| Nikhil PereiraKamath | Chief Officer | Profile | |
| Pharm MPH | Senior Relations | Profile | |
| Libbie MD | Chief Officer | Profile | |
| MPH MD | Senior Procedures | Profile |
About ProKidney Corp Management Performance
The success or failure of an entity such as ProKidney Corp often depends on how effective the management is. ProKidney Corp management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of ProKidney management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the ProKidney management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.14) | (0.15) | |
| Return On Capital Employed | (0.45) | (0.48) | |
| Return On Assets | (0.14) | (0.15) | |
| Return On Equity | 0.06 | 0.06 |
ProKidney Corp Workforce Analysis
Traditionally, organizations such as ProKidney Corp use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare ProKidney Corp within its industry.ProKidney Corp Manpower Efficiency
Return on ProKidney Corp Manpower
| Revenue Per Employee | 373 | |
| Revenue Per Executive | 3.6K | |
| Net Loss Per Employee | 800.7K | |
| Net Loss Per Executive | 7.8M | |
| Working Capital Per Employee | 1.8M | |
| Working Capital Per Executive | 17.1M |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in ProKidney Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. For more information on how to buy ProKidney Stock please use our How to buy in ProKidney Stock guide.You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ProKidney Corp. If investors know ProKidney will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ProKidney Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of ProKidney Corp is measured differently than its book value, which is the value of ProKidney that is recorded on the company's balance sheet. Investors also form their own opinion of ProKidney Corp's value that differs from its market value or its book value, called intrinsic value, which is ProKidney Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ProKidney Corp's market value can be influenced by many factors that don't directly affect ProKidney Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ProKidney Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if ProKidney Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ProKidney Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.